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Summary
Stem cells of the gastrointestinal tract, pancreas, liver, and other columnar epithelia collectively 
resist cloning in their elemental states. Here we demonstrate the cloning and propagation of highly 
clonogenic, “ground state” stem cells of the human intestine and colon. We show that derived stem 
cell pedigrees sustain limited copy number and sequence variation despite extensive serial 
passaging and display exquisitely precise, cell-autonomous commitment to epithelial 
differentiation consistent with their origins along the intestinal tract. This developmentally 
patterned and epigenetically maintained commitment of stem cells likely enforces the functional 
specificity of the adult intestinal tract. Using clonally-derived colonic epithelia, we show that 
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toxins A or B of the enteric pathogen C. difficile recapitulate the salient features of 
pseudomembranous colitis. The stability of the epigenetic commitment programs of these stem 
cells, coupled with their unlimited replicative expansion and maintained clonogenicity, suggests 
certain advantages for their use in disease modeling and regenerative medicine.
Introduction
While dominating prospective strategies for regenerative medicine, embryonic stem cells 
(ESC) and induced pluripotent stem cells (iPSC) face formidable challenges including risk 
of teratoma, complex guiding protocols for lineage specificity, and limited regenerative 
capacity of the lineages ultimately produced3–8. The success and promise of iPSCs have 
largely overshadowed efforts to harness stem cells intrinsic to regenerative tissues. Green 
and colleagues developed methods for cloning epidermal stem cells9 that form a stratified 
epithelium upon engraftment, and these methods have been successfully applied to corneal, 
thymic, and airway epithelia10–12. However, stem cells of columnar epithelial tissues resist 
cloning in a manner that maintains their immaturity during proliferative expansion, and 
instead must be carried forward as regenerative, differentiating “organoids”13–18. Despite 
their obvious potential in regenerative medicine and constant improvement19, the very low 
percentage of clonogenic cells in organoids limits the kinetics of their propagation as well as 
their utility for exploring the elemental stem cell.
The present study reports the cloning and propagation of “ground state” human intestinal 
stem cells (ISCGS). This technology offers insights into the molecular and functional 
features of columnar epithelial stem cells and their utility for disease modeling and 
regenerative medicine.
Cloning human fetal intestinal stem cells
We developed media (herein SCM-6F8) containing novel combinations of growth factors 
and regulators of TGF-β/BMI1, Wnt/β-catenin, EGF, IGF, and Notch pathways9,20–21 that 
supports the maintenance of human intestinal stem cells in a highly clonogenic, ground state 
form. Thus single cell suspensions of intestinal epithelia derived from 20- to 22-week-old 
fetal demise cases yield colonies comprised of highly immature cells in which differentiation 
markers can be induced by Notch suppression (Fig. 1a). Following induced differentiation 
via Wnt withdrawal, we were unable to recover ground state stem cells by our methods 
(Extended Data Fig. 1).
The clonogenicity of cells in the colonies was determined by single cell transfer to be greater 
than 50% (Fig. 1b). This high clonogenicity permits the rapid generation of single cell 
“pedigree” lines for expansion and characterization of lineage fates upon differentiation12 
(Fig. 1b). Pedigree lines of ISCGS and tracheobronchial stem cells (TBSCGS)12 grown for 
several months in culture were differentiated in air-liquid interface (ALI) cultures for 10–30 
days (Fig. 1c). The ISCGS formed a highly uniform, 3-D serpentine pattern, whereas 
TBSCGS produced a stratified epithelium with apically positioned ciliated and goblet cells. 
Histological sections of differentiated ICSGS revealed a columnar epithelium of villus-like 
structures marked by goblet (Muc2+), endocrine (chromogranin A+), and Paneth cells and 
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polarized villin expression (Fig. 1d; Extended Data Fig. 1d), indicating the progeny of a 
single ISCGS can give rise to all epithelial lineages typically found in the small intestine. 
Importantly, differentiation of these ground state stem cells is accomplished by exposure to 
an air-liquid interface rather than a removal of factors such as Wnt that maintain immaturity.
While principal component analysis (PCA) of differentially expressed genes of ground state 
stem cells and ALI differentiated tissue showed great divergence as expected for columnar 
and stratified epithelia, the gene expression profiles of undifferentiated ISCGS and TBSCGS 
differed by less than 4% (>2.0-fold, p<0.05) (Fig. 1e). ISCGS showed high expression of 
intestinal stem cell markers such as OLFM4, CD13322, Lgr523, and Lrig124, whereas those 
from the airways had the typical stem cells markers of stratified epithelia (Krt14, Krt5, and 
Tp6311) (Fig. 1f).
Intestinal stem cell variation
Approximately one in 2,000 cells from duodenum (IduSC), jejunum (IjeSC), and ileum 
(IilSC) of a 21-week old fetal intestine form a colony (Fig. 2a). Although these colonies 
were morphologically indistinguishable in culture, whole genome expression analysis of 
multiple pedigrees showed a consistent, region-specific signature of 24–178 genes (>1.5-
fold, p<0.05; Fig. 2b; Extended Data Fig. 2).
After 10 days at an ALI, IduSC and IjeSC gave rise to a finer pattern of epithelial folds than 
that produced by IilSC (Fig. 2c). By histology, villi appear progressively more robust along 
the anterior-posterior axis, with IilSC producing the larger villi and more numerous goblet 
cells (Fig. 2d,e). Interestingly, the epithelia derived from IduSC expressed markers more 
typical of gastric epithelium (e.g. TFF2 and Muc5AC) consistent duodenum’s location 
between the stomach and the small intestine (Extended Data Fig. 2a,b,c). IjeSC-derived 
epithelium, however, expressed Muc2 consistent with intestinal epithelium (Extended Data 
Fig. 2c), and IilSC produced an epithelium more akin to colon (Fig. 2f). The pattern of 
proliferation in the ALI epithelia as measured by Ki67 staining was generally confined to 
cells proximal to the support membrane (Fig. 2e,f). PCA mapping of gene expression 
revealed more divergence among ALI-differentiated tissue than among the intestinal stem 
cells (Fig. 2g).
Colon stem cells
We also generated single cell pedigree lines from the ascending, transverse, and descending 
colon from the same 21-week fetal demise case (Fig. 3a). The variation in gene expression 
between the stem cells of these colonic segments was minimal with signatures of 19–28 
genes (>1.5-fold, p<0.05; Fig. 3b). As with pedigrees derived from the intestinal epithelium, 
those from the colon could be propagated for months without loss of clonogenicity (not 
shown). Differentiation of these colon pedigrees under identical ALI conditions employed 
for the intestinal stem cells resulted in networks of 3-D, large-diameter structures (Fig. 3c). 
Consistently, the histology of these ALI cultures revealed patterns of broad intestinal glands 
dominated by goblet cells (Fig. 3d). These ALI-generated tissues showed strong staining for 
intestinal goblet cell marker Muc2, as well as polarized villin and Krt20 typical of 
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differentiated colonic epithelium (Fig. 3e). And while the colonic stem cells as a group 
showed minor differences in gene expression (cf. Fig. 3b), they gave rise to epithelia with 
more distinct gene expression profiles (Extended Data Fig. 3). PCA mapping of these 
expression data showed a clustering of the colon stem cells relative to the intestinal stem 
cells with increasingly distant spaces occupied by stem cells of the ileum, jejunum, and 
duodenum, respectively (Fig. 3f). This distinction in global gene expression patterns is 
reflected, for instance, in the differential expression of transcription factors. In particular, 
Onecut2, NROB2, TRPS1, and ZNF503 show relatively high expression in the small 
intestine stem cells, whereas those of the colon showed a bias for Hox genes as well as the 
global chromatin organizer genes SATB1 and SATB2 (Fig. 3g,h).
Columnar versus stratified epithelia
The expression profiles of stem cells of human intestinal tract enabled a detailed comparison 
with those of stratified epithelia including human epidermis, corneal epithelium, mammary 
gland, prostate gland, and upper airway. From this analysis it is clear that stratified epithelia, 
all of which depend on the p53-related stem cell marker p63 for long-term self-renewal11, 
occupy a distinct expression space from that of the intestinal stem cells or other columnar 
epithelial stem cells (Fig. 4a). A survey of genes whose expression is associated with stem 
cells of one of these two major classes of epithelia revealed a strong bias for Olfm4, 
CD13322, Lgr523, Nr5a225, Id2, Lrig124, EphB2, Ascl2, and EphB3 in the intestinal stem 
cells, while the stratified epithelial stem cells expressed Znf750, Tp63, and Krt5 (Fig. 4b). 
Many of the markers differentially appearing in the intestinal stem cells, such as Olfm4, 
Lgr5, and Ascl2, are not general columnar epithelial stem cell markers as evidenced by their 
absence in fallopian tube stem cells, though Lrig1 is more highly expressed in fallopian tube 
stem cells than either those of the intestine or the colon (Extended Data Fig. 4a). Notably, 
Bmi1, a member of the Polycomb group (PcG) PRC1-like complex implicated in self-
renewal in both hematopoietic26 and as reserve cells for proliferating, Lgr5+ intestinal stem 
cells27–29, was not differentially expressed in the cloned intestinal versus stratified epithelial 
stem cells. And while many of the typical markers of intestinal stem cells such as Lgr5, 
CD44, Lrig1, EphB2, and ASCL2 show a decrease in expression as the intestinal stem cells 
are differentiated in ALI cultures, Bmi1 did not (Extended Data Fig. 4b,c). These findings 
suggest that we are cloning either crypt cells or so-called “+4” cells that have become crypt-
like in their expression patterns. We also examined transcription factors differentially 
expressed in ISC compared to stratified epithelial stem cells in an effort to understand the 
regiospecificity of commitment programs of stem cells along the intestinal tract (Fig. 4c). In 
addition to six transcription factors that were uniformly highly expressed in stem cells of the 
intestinal tract (CREB3L1, Myb, NR5A2, IRF8, HNF4G, and Msx2) versus 
tracheobronchial stem cells, this analysis revealed limited sets of transcription factors 
differentially expressed in stem cells along the anterior-posterior axis of the intestinal tract 
that conceivably function in maintaining commitment states. For instance and consistent 
with previous observations30, GATA4 and GATA6 were expressed most strongly in the 
anterior portions of the intestinal tract (Fig. 4c). Significantly, the selective deletion of 
GATA4 and GATA6 in the murine duodenum and jejunum results promotes ileal properties 
and a detrimental phenotype30,31, suggesting a role for these transcription factors in 
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maintaining segmental identity acting at the level of the stem cell. Similarly, the requirement 
for Onecut2 in the duodenum32 might be at the level of the duodenal stem cells. It is likely 
that analyses of cloned stem cells from the various segments of the intestinal tract will help 
to unravel the roles of such segment-specific transcription factors in the establishment of 
commitment and differentiation programs. Importantly, the overall properties of ISCs from 
fetal sources are conserved in those derived from endoscopic biopsies of pediatric and adult 
cases (Fig. 4d,e,f).
Genomic and lineage stability
Human ESC and iPSC lines acquire with successive passages genomic structural variations 
including some that confer a selective advantage33,34. To assess the genomic stability of our 
ISCGS, we examined copy number (CNV) and single nucleotide variation (SNV) in two 
independent ISCGS pedigrees derived from the ileum of one fetal demise case after 50 
(passage 5; P5), 100 (P10), 150 (P15), and 200 days (P20) of continuous proliferation (Fig. 
5a,b). At P5, when single ISCGS pedigrees can be amplified to an estimated 300 million to 
75 billion cells, no chromosomal aneuploidies were detected, though one pedigree showed 
three interstitial deletions affecting two genes (Fig. 5c; Extended Data Fig. 5a; SI Table 1). 
This low level of structural variation was maintained though passage 10 though increased by 
P15 and at P20 one of the pedigrees showed a frank trisomy of chromosome 12 (Fig. 5c; 
Extended Data Fig. 5a; SI Table 1). A similar upward trend in CNV as a function of passage 
number was observed in five intestinal pedigrees (pedigrees 3–7) derived from a separate 
fetal demise case (Extended Data Figs. 5, 6; SI Tables 1, 2).
By exome sequencing, our original two pedigrees showed few (0–1) non-synonymous 
mutations through passage 10, and these increased modestly (1–2 new non-synonymous 
mutations) through P15 and P20 (Extended Data Fig. 5a). None of these non-synonymous 
mutations have been reported as driver genes in human cancers. A similar trend was 
observed in the five pedigrees from the second fetal demise case followed through P5 and 
P25. By P25 the range of non-synonymous SNVs increased to 2–10 per clone, and while not 
involving obvious cancer driver genes, did include genes such as Ect2L and EP300 that 
might provide a selective growth advantage (Extended Data Fig. 5c). These data indicate that 
most pedigrees sustain few genomic changes within the first 100 days of proliferative 
expansion. By P15 and through P25, however, half the pedigrees showed evidence for 
aneuploidy as well as an increase in interstitial CNV and SNVs with allele frequencies 
nearing 0.5, suggesting the rise of an advantaged subclone. We asked how these late passage 
genomic changes might impact differentiation by comparing early and late passages of 
pedigree 2 in ALI differentiation. By all histological criteria, including Alcian blue staining 
for goblet cells and intestinal marker staining, we could not distinguish the ALI 
differentiated epithelia derived from P7, P17, and p27 (Fig. 5d; Extended Data Fig. 7). 
Similarly, we note that these intestinal stem cell pedigrees do not lose (or gain) 
clonogenicity when tested at P7 and p16, which remain stably above 50% (Fig. 5e,f). Lastly, 
we found no evidence of tumorigenicity by these ground state intestinal stem cells, including 
those at P25 harboring aneuploidies, following their subcutaneous implantation to 
immunodeficient (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) mice35 (Extended Data Fig. 8).
Wang et al. Page 5





















Modeling C. difficile infections
Clostridium difficile (Cd) is a gram-positive, spore-forming bacterium and the primary cause 
of nosocomial diarrhea and pseudomembranous colitis36. The pathogenicity of Cd is linked 
to its production of two similar, high molecular weight toxins TcdA and TcdB. While 
together TcdA and TcdB cause fluid secretion, inflammation, and colonic tissue damage, 
their respective and possible synergistic roles have been difficult to ascertain37–39. We 
therefore challenged colonic epithelia derived from cloned, ground state colonic stem cells 
with recombinant TcdB (Fig. 6a,b; Extended Data Fig. 9a,b). At higher concentrations or 
longer time points there is a loss of goblet cells, disruption of the crypt architecture, cell 
polarity, and a specific loss of tight versus adherens junction proteins that correlates with 
increased dextran permeability (Fig. 6c). These dose-response changes in the ALI colonic 
epithelium mirror those of C. difficile-associated pseudomembranous colitis (Fig. 6d, 
Extended Data Fig. 9a,b). Microarray analysis of ALI-generated colonic epithelia following 
nine TcdB treatment conditions revealed alterations in gene expression in a time- and dose-
dependent manner (Fig. 6e,f; Extended Data Fig. 9c–f). Pathway analysis indicated that 
TcdB triggers changes in gene expression related to inflammation, RhoB-mediated actin 
regulation, and junctional dynamics previously implicated in C. difficile pathology40,41. In 
addition, this analysis revealed that DUOX2 and DUOXA2 were consistently the two 
highest up-regulated genes (Fig. 6e,f). These proteins form an enzyme capable of producing 
hydrogen peroxide and have been implicated in the inflammation of inflammatory bowel 
disease (IBD)42. Finally, we also tested C. difficile TcdA in our model. TcdA is reported to 
be a specific enterotoxin36,37, and indeed we found that it triggers similar cytopathic and 
permeability changes in ALI models of human colonic epithelium (Extended Data Fig. 10), 
albeit at lower doses than those effective for TcdB. Together these findings underscore the 
potential of this model system to recapitulate and elucidate C. difficile pathology.
Discussion
Adult stem cells of the highly regenerative intestinal tract remain largely defined by 
metabolic, marker profiling, or lineage tracing experiments in vivo or transplantation of cells 
from intestinal organoids23, 43–44. As stem cells comprise only minor component of 
organoids- perhaps less than 1%45, the molecular features of stem cells of columnar 
epithelia such as the intestinal tract have remained unclear. Therefore the selective cloning 
and proliferative expansion of highly clonogenic, ground state intestinal stem cells described 
here offers a first glimpse into the molecular properties of these cells. Our inability to 
convert differentiated cells to clonogenic cells supports the notion that we are cloning 
resident stem cells rather than somehow “reprograming” differentiated enterocytes. These 
resident stem cells possess robust epigenetic programs of commitment to regiospecific 
intestinal differentiation that are stable despite more than six months of continuous 
propagation. This cell-autonomous regiospecificity of stem cells along the intestinal tract 
argues against a unitary “intestinal stem cell” or even one each for the histologically 
recognized segments but rather a developmentally established spectrum of stem cells that 
ultimately maintains the histological and functional properties that define these segments. 
An heuristic deciphering of the commitment code from the regiospecific expression patterns 
presented here will guide parallel efforts with iPSCs to achieve appropriate lineage fates46. 
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Interestingly, many inductive signaling pathways and transcription factors implicated in 
embryonic gut formation47 may act to reinforce commitment codes via continued expression 
in stem cells of the intestinal tract.
We anticipate that the ability to maintain these stem cells in their elemental state will enable 
the discovery of epigenetic mechanisms that underlie properties of very long-term self-
renewal, exquisitely precise lineage commitment, and the intrinsically directed, self-
assembly of differentiated epithelia. Though we demonstrate the potential of clonally-
derived colonic epithelia to model the pathogenesis of C. difficile toxins, we anticipate the 
need to restore complexity in the form of mesenchyme, immune cells, enteric neurons, and 
perhaps components of the microbiome48 to fully recapitulate disease dynamics. In 
particular, enteric maladies such as inflammatory bowel disease represent significant 
medical challenges whose etiologies most likely reside in interactions between the immune 
system, intestinal mucosa, and intestinal flora49,50. Finally, the ability to clone patient-
specific, ground state stem cells from endoscopic biopsies, coupled with their orders-of-
magnitude expansion kinetics over organoids, favors their use in regenerative medicine, pre-
clinical trials, and disease modeling.
Methods
In vitro culture of human small intestinal and colonic epithelial stem cells
Intestinal tissue from 20- to 21-week-old late fetal demise cases were obtained under parent 
consent as de-identified material under approved institutional review board protocols at the 
Brigham and Women’s Hospital, Boston, MA, USA (2009P002281). Terminal ileum 
endoscopic biopsies were obtained under informed consent and institutional review board 
approval at the Connecticut Children’s Medical Center, Hartford, CT USA (15-047J-2). 
Fetal intestinal tissue or 1 mm endoscopic biopsies from terminal ileum were collected into 
cold F12 media (Gibco, USA) with 5% fetal bovine serum (HyClone, USA) and then 
minced by sterile scalpel into 0.2–0.5 mm3 sizes to a viscous and homogeneous appearance. 
The minced tissue was digested in 2 mg/ml collagenase type IV (Gibco, USA) at 37°C for 
30–60 min with agitation. Dissociated cells were passed through a 70 μm Nylon mesh 
(Falcon, USA) to remove aggregates and then were washed four times in cold F12 media, 
and then seeded onto a feeder layer of lethally irradiated 3T3-J2 cells9,12 in c-FAD media9 
modified to SCM-6F8 media by the addition of 125 ng/mL R-spondin1 (R&D systems, 
USA), 1 μM Jagged-1 (AnaSpec Inc, USA), 100 ng/ml human Noggin (Peprotech, USA), 
2.5 μM Rock-inhibitor (Calbiochem, USA), 2 μM SB431542 (Cayman chemical, USA), and 
10 mM nicotinamide (Sigma-Aldrich, USA). Cells were cultured at 37°C in a 7.5% CO2 
incubator. The culture media was replaced every two days. Colonies were digested by 
0.25 % trypsin-EDTA solution (Gibco, USA) for 5–8 min and passaged every 7 to 10 days. 
Colonies were trypsinized by TrypLE Express solution (Gibco, USA) for 8–15 min at 37°C 
and cell suspensions were passed through 30 μm filters (Miltenyi Biotec, Germany). 
Approximately 20,000 epithelial cells were seeded to each well of 6-well plate. Cloning 
cylinder (Pyrex, USA) and high vacuum grease (Dow Corning, USA) were used to select 
single colonies for pedigrees. Gene expression analyses were performed on cells derived 
from passage 4–8 (P4–P8) cultures.
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Histology, hematoxylin and eosin (H&E), Alcian blue, Periodic acid–Schiff (PAS), 
Rhodamine B staining, immunohistochemistry, and immunofluorescence were performed 
using standard techniques. For immunofluorescence and immunohistochemistry, 4% 
paraformaldehyde-fixed, paraffin embedded tissue sections were subjected to antigen 
retrieval in citrate buffer (pH 6.0, Sigma-Aldrich, USA) at 120 °C for 20 min, and a blocking 
procedure was performed with 5% bovine serum albumin (BSA, Sigma-Aldrich, USA) and 
0.05 % Triton X-100 (Sigma-Aldrich, USA) in phosphate-buffered saline (PBS; Gibco, 
USA) at room temperature for 1 hr. Primary antibodies used in this study and staining 
condition were listed in Supplementary Information Table 3. All images were captured by 
using the Inverted Eclipse Ti-Series (Nikon, Japan) microscope with Lumencor SOLA light 
engine and Andor Technology Clara Interline CCD camera and NIS-Elements Advanced 
Research v.4.13 software (Nikon, Japan) or LSM 780 confocal microscope (Carl Zeiss, 
Germany) with LSM software. Bright field cell culture images were obtained on an Eclipse 
TS100 microscope (Nikon, Japan) with Digital Sight DSFi1camera (Nikon, Japan) and NIS-
Elements F3.0 software (Nikon, Japan).
Stem cell differentiation
Air-liquid interface (ALI) culture of intestinal and colonic epithelial cells was performed as 
described12,51. Briefly, Transwell inserts (Corning, USA) were coated with 20% Matrigel 
(BD Biosciences, USA) and incubated at 37 °C for 30 min to polymerize. 200,000 irradiated 
3T3-J2 cells were seeded to each transwell insert and incubated at 37 °C, 7.5% CO2 
incubator overnight. QuadroMACS Starting Kit (LS) (Miltenyi Biotec, Germany) was used 
to purify the stem cells by removal of feeder cells. 200,000–300,000 stem cells were seeded 
into each Transwell insert and cultured with SCM-6F8. At confluency (3–7 days), the apical 
media was removed through careful pipetting and the cultures were continued for an 
additional 6–12 days before analysis.
Clostridium difficile toxin treatment and epithelial permeability assay
Clostridium difficile toxins A and B (TcdA, TcdB) were prepared as described52. Intestinal 
stem cells were differentiated in air-liquid interface cultures as described above and treated 
with 100, 250, 500 pM and 10 nM TcdA or TcdB for 0, 8, 16, and 24 hr). At these time 
points, membranes with differentiated epithelia were collected for histology and microarray 
analysis. 4kDa FITC-dextran (Sigma-Aldrich, USA) was added to the apical chamber of the 
Transwell chambers for a final concentration of 0.5 mg/ml. Media was removed from the 
bottom compartment after different incubation times and fluorescence was read by 
fluorometer (Infinite® M1000 PRO, excitation 490 nm, emission 520 nm, Tecan, USA).
Implantation of intestinal stem cells
Intestinal stem cells (1.5 million cells) from different pedigrees with 50 % of Matrigel (BD 
Bioscience, USA) were subcutaneously implanted into female, six-eight-week-old 
immunodeficient (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) mice35 under IACUC approval 
(100533-1115) To test spontaneous transformation of the stem cells, mice were monitored 
every month (up to 4 months).
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RNA and genomic DNA sample preparation
For stem cell colonies, RNA was isolated using PicoPure RNA Isolation Kit (Life 
Technologies, USA). For ALI-differentiated epithelia, RNA was isolated using Trizol RNA 
Isolation Kit (Life Technologies, USA). RNA quality (RNA integrity number, RIN) was 
measured by analysis Agilent 2100 Bioanalyzer and Agilent RNA 6000 Nano Kit (Agilent 
Technologies, USA). RNAs having a RIN > 8 were used for microarray analysis. Genomic 
DNA was extracted with DNeasy Blood & Tissue kit (Qiagen, Netherlands) from intestinal 
and colonic stem cells for CNV analysis and exome capture sequencing. For genomic DNA 
extraction, human intestinal and colonic stem cells were isolated from mouse 3T3 feeder 
layer using QuadroMACS Starting Kit (Miltenyi Biotec, Germany). Genomic DNA 
concentration was measured with Qubit® dsDNA BR Assay Kit (Life Technologies, USA).
Expression microarray and bioinformatics
Total RNAs obtained from immature colonies and ALI differentiated structure were used for 
microarray preparation with WT Pico RNA Amplification System V2 for amplification of 
DNA and Encore Biotin Module for fragmentation and biotin labeling (NuGEN 
Technologies, USA). RNA quality (RNA integrity number, RIN) was measured by analysis 
using an Agilent 2100 Bioanalyzer and Agilent RNA 6000 Nano Kit (Agilent Technologies, 
USA). RNAs having a RIN > 8 were used for microarray analysis. All samples were 
prepared according to manufacturer’s instructions and hybridized onto GeneChip Human 
Exon 1.0 ST Array (Affymetrix, USA). GeneChip operating software was used to process all 
the Cel files and calculate probe intensity values. To validate sample quality, quality checks 
were conducted using Affymetrix Expression Console software. The intensity values were 
log2-transformed and imported into the Partek Genomics Suite 6.6 (Partek Incorporated, 
USA). Exons were summarized to genes and a 1-way ANOVA was performed to identify 
differentially expressed genes. For two sample statistics, p-values were calculated by student 
t-test for each analysis. Unsupervised clustering and heatmap generation were performed 
with sorted datasets by Euclidean distance based on average linkage clustering, and 
Principal Component Analysis (PCA) map was conducted using all or selected probe sets by 
Partek Genomics Suite 6.6. Gene Set Enrichment Analysis (GSEA)53 was performed for C. 
diff toxin B treatment. For the region-specific gene signature of small intestine and colon 
comparison (PD, PJ and MI for Figure 2b and AC, TC and DC for Figure 3b), differentially-
expressed genes were selected with a cutoff value of 1.5 fold and p < 0.05 in each 
comparison (e.g. 1) PD vs. PJ and 2) PD vs. MI) and then intersected genes in 2 gene lists of 
each comparison were taken as regio-specific gene sets. In the heatmaps (Fig. 2b and 3b), 3 
regio-specific gene sets (PD, PJ and MI, or AC, TC and DC) were combined, and the 
heatmaps were made with Euclidean distance based on average linkage clustering. For C. 
difficile toxin B treatment data sets, samples from indicated time points and dosages were 
compared with control (untreated samples). Differentially-expressed genes (2-fold up-
regulated and down-regulated genes) were counted and plotted in 3D column plots 
(Extended Data Figure 8c). In comparison of 500 pM 24 hrs toxin B treatment with control, 
39 genes were significantly upregulated (cutoff value: 3 fold and p < 0.05) and a heatmap 
(Figure 6e) was made with 39 genes using all samples. The whole genome expression data 
of 500 pM 24 hrs toxin B treatment vs. control were applied to GSEA program to detect 
significantly enriched pathway in toxin B treatment. Selected pathways (from KEGG) were 
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shown in Figure 6d. Datasets generated for this study have been submitted to the National 
Center for Biotechnology Information Gene Expression Omnibus (GEO) database under 
files GSE57584 and GSE63880.
Copy number variation
For copy number variation analysis of stem cell pedigrees and passage 0 pooled sample, 
genomic DNA samples were genotyped with HumanOmniExpress BeadChip Kit for clone 1 
and 2 (passage 5, 10, 15 and 20) (Illumina, USA) and Illumina HumanOmniZhonghua 
BeadChip Kit for clones 3 to 7(passage 5 and 25) following the manufacturer’s instructions. 
Analysis of BeadChip was performed using GenomeStudio Software (Illumina, USA). 
Illumina high-density SNP genotyping data was converted to kilobase-resolution detection 
of copy number variation. CNV detected in passage 0 pooled samples are considered as 
germline CNVs and removed in the analysis. The data was generated by PennCNV54. Genes 
within 10Kb of CNV regions are reported. The parameter is set as “-expandleft 10k” and “-
expandright 10k”. Other parameters are default. Confidence score > 10 was used as a cutoff. 
The call rates for CNV were all greater than 99%, and two larger CNV amplification and 
deletion events were validated by quantitative PCR.
Exome capture sequencing
For Exome capture and high-throughput sequencing for intestinal stem cells (pedigree 1 and 
2), 50 ng of gDNA was used to perform Nextera Expanded Exome Kit (Illumina, USA). For 
pedigree 3 to 7, 1μg of genomic DNA was sheared using a Covaris S1 Ultrasonicator 
(Covaris, USA), end-repaired, A-tailed, and Adaptor-ligated. Exome capture was performed 
using a Tru-seq Exome Enrichment Kit (Illumina, USA) following the manufacturer’s 
instructions. Multiplexed libraries were sequenced on an Illumina HiSeq sequencer using 
101-bp paired-end reads. Reads were aligned to the reference genome (UCSC hg19) using 
Burrows Wheeler Aligner (BWA, 0.6.2)55. PCR duplicates were removed using 
PICARD-1.94 (http://picard.sourceforge.net). The Genome Analysis Toolkit (GATK 
framework version 2.6.4)56 was used to realign reads near indels and to recalibrate base 
quality values.
When running GATK, the minimum phred-scaled confidence threshold at which variants 
were called (-stand_call_conf) was 50, and the minimum phred-scaled confidence threshold 
at which variants were emitted (-stand_emit_conf) is 30. The criteria of GATK Variant 
Filtration is as follows: --clusterWindowSize 10 --filterExpression “MQ0>4 && ((MQ0/
(1.0*DP))>0.1)” --filterName “HARD_TO_VALIDATE” --filterExpression “DP<5” --
filterName “LowCoverage” --filterExpression “QUAL<30” --filterName “VeryLowQual” --
filterExpression “QUAL>30 && QUAL<50” --filterName “LowQual” --filterExpression 
“QD<1.5” --filterName “LowQD” --filterExpression “FS>150” --filterName “StrandBias”. 
Potential mouse genomic DNA contaminant reads were detected by alignment to the mouse 
genome (UCSC mm10) and those containing less than 3 mismatches were removed from 
further analysis. SNVs were called in each sample separately using SAMtools- v0.1.1957 
and GATK in the exome capture targeted regions. Variants with at least Q50 confidence, 
phred-scaled quality score more than 40 and coverage higher than 10 were considered as 
true SNVs. Variants were annotated with ANNOVAR (version 11 Feb, 2013)58. Identical 
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variant calls in intestinal stem cells (passage 5 and higher) when compared to passage 0 
pooled samples were used to identify germline SNVs. Sanger sequencing validation was 
performed using primers designed with Primer3 software version 4.0 (http://
frodo.wi.mit.edu/). Extracted genomic DNA was amplified with titanium taq polymerase 
(Clontech Laboratories, CA, USA) and purified PCR products were sequenced in the 
forward directions using ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction 
kits and an ABI PRISM 3730 Genetic Analyzer (Applied Biosystems, CA, USA). We 
validated by PCR and Sanger sequencing 13 of 14 non-synonymous mutations called by our 
sequencing efforts suggesting a false discovery rate of less than 10%. Other quality control 
parameters are shown in Supplementary Information Table 4.
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Extended Data Fig. 1. Loss of clonogenicity in differentiated ISC
a. Schematic of ISC differentiation using either the gamma-secretase inhibitor 
dibenzazepine (DBZ) or withdrawal of the Wnt regulator R-spondin 1 (Rspo1). ISCs were 
plated on day 0, DBZ added or Rspo1 removed at day 2, and colonies passaged en mass at 
day 7. At day 14, after 7 days of continuous growth, colonies were counted. b. Micrographs 
show immunofluorescence at day 7 colonies grown without Rspo1 or in the presence of 
DBZ for five days using antibodies to Ki67, chromogranin A (CHGA), keratin 20 (Krt20), 
E-cadherin (E-cad), and mucin 2 (Muc2). Scale bar, 50um; n=4 technical replicates. c. 
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Histogram shows colony formation in each condition normalized to control ISCs. n=4 
biological replicates; Error bars, SD. d. Staining of ALI-differentiated intestinal stem cells 
with monoclonal antibody HD6 directed to Paneth cells. Scale bar, 50um; n=4 technical 
replicates.
Extended Data Fig. 2. Intestinal stem cell expression profiles
a. List of genes differentially expressed in ISC derived from duodenum, jejunum and ileum. 
These data correspond to heatmap of Fig. 2b. b. Immunofluorescence labeling of ALI-
differentiated ISCs from duodenum with antibodies against Tff2, mucin 5AC, villin, E-
cadherin, and mucin 2. c. Immunofluorescence labeling of ALI-differentiated epithelia from 
jejunum stem cells with antibodies to E-cadherin, mucin 2, villin, and mucin 5AC. Scale bar, 
50um; n=10 technical replicates.
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Extended Data Fig. 3. Differential gene expression in epithelia derived from colonic stem cells
Heatmap of differentially expressed (>1.5-fold, p<0.05) genes in ALI cultures derived from 
stem cell pedigrees of ascending, transverse, and descending colon.
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Extended Data Fig. 4. Differential gene expression across columnar and stratified epithelial stem 
cells
a. Histograms of expression microarray signal intensity of selected genes across averaged 
intestine and colon ISCs, stratified epithelial stem cells, and stem cells of the fallopian tube. 
Biological replicas n=2–6 (FT=2, stratified epithelia=3, colon, intestine=6); Error bars, SD. 
b. Dot plot showing expression microarray data of indicated genes for stem cell pedigrees 
(ISC; Duo, duodenum; Jej, jejunum; Ile, ileum; AC, ascending colon; TC, transverse colon; 
DC, descending colon) derived from various regions of the intestinal tract before and after 
air-liquid interface (ALI) differentiation. Biological replicas n=2 (total 12 datasets) for stem 
cells, technical replicas n=2 for ALI. c. Chart of aggregate p-values by Student t-test for 
gene expression changes between ground state stem cells and their ALI-differentiated 
counterparts.
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Extended Data Fig. 5. Genes impacted by CNV and SNV events in intestinal stem cell pedigrees 
during passaging
a. Summary of CNV [events (genes affected)] and non-synonymous SNV in pedigrees 1 and 
2 at P5 to P20. b. Summary of genes altered by interstitial CNV amplifications (top) or 
deletions (bottom) in ISC pedigrees no. 3 to 7 at P5 and P25. c. Summary of genes 
sustaining non-synonymous SNV in five ISC pedigrees at P5 and P25.
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Extended Data Fig. 6. 
Whole genome CNV profiles for intestinal stem cell pedigrees 3–7 at P5 and P25. Regions 
marked by ovals represent aneuploidy.
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Extended Data Fig. 7. Impact of ISCGS passaging on ALI differentiation
ALI differentiation of intestinal pedigree 2 initiated from cells at the indicated passage 
number. As indicated, histological sections of differentiated epithelia were stained with 
antibodies to either E-cadherin (ECAD, green) and mucin 2 (Muc2, red), or Ki67 (green) 
and chromogranin A (CHGA, red). Scale bar, 75um; n=4 technical replicates.
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Extended Data Fig. 8. ISCGS tumorigenicity assays in immunodeficient mice
a. Quantification of tumor formation assesses at 4–16 weeks following subcutaneous 
innoculation of two million cells of the indicated ISC pedigrees at passage 6 or passage 25 at 
4–16 weeks. “Pool” indicates total set of clones derived from P0 ileum culture prior to 
pedigree generation. “Cancer cells” refers to propagating cells from case of high-grade 
serous ovarian cancer. b. Left, Histological section through site of injection of 1 million cells 
from pedigree 3. Right, Section of injection site stained with antibody (STEM121) to human 
epithelial cells (brown) revealing benign cysts. Scale bar, 15um.
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Extended Data Fig. 9. Dose- and time-dependency of TcdB pathology in ALI-generated colonic 
epithelia
a. Immunofluorescence localization of adherens junction marker E-cadherin and tight 
junction marker claudin 3 in ALI differentiated epithelia derived from transverse colon stem 
cells following exposure to 100pM TcdB for the indicated durations. n=4 technical 
replicates. Scale bar, 100um. b. Representative H&E images of ALI cultures at indicated 
times and concentration of TcdB exposure. Scale bar, 250um; n=4 technical replicates. c. 
Gene Set Enrichment Analysis of whole genome expression data from colonic epithelia 
treated with 500pM TcdB for 24 hrs. and control samples showing enriched KEGG pathway 
sets. NES: normalized enrichment score; NOM p-value: nominal p-value. d. 3D plot of up-
regulated genes at the indicated time points and dosages >2-fold, p<0.05). n=2 technical 
replicates. e. Heatmap of up-regulated genes in 500 pM TcdB samples. The genes (237 
genes) were chosen by cutoff values (>2-fold, p < 0.05). Three time points (8, 16 and 24 hrs) 
are shown. f. 3D plot of down-regulated genes at the indicated time points and dosages >2-
fold, p<0.05). n=2 technical replicates.
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Extended Data Fig. 10. Dose- and time-dependency of TcdA pathology in ALI-generated colonic 
epithelia
a. left, Representative H&E images of ALI cultures at indicated times and concentration of 
TcdA exposure; right, Immunofluorescence localization of adherens junction marker E-
cadherin (ECAD; green) and mucin 2 (MUC2; red) in ALI differentiated epithelia derived 
from transverse colon stem cells following incubation with 10nM TcdA for the indicated 
durations. Scale bar, 100um; n=4 technical replicates. b. 3-D plot of histological scoring of 
representative H&E time points and concentrations performed by gastrointestinal pathologist 
according to a standard 0–3 rating for colonic epithelial integrity. c. Distribution of tight 
junction marker claudin 3 (Cldn3) and adherens junction marker (Cdh17) following 
treatment of ALI colonic epithelium with TcdA for the indicated times and doses. Scale bar, 
50um; n=4 technical replicates. d. Histogram of permeability of ALI colonic epithelium 
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(Papp) to small molecules (FD4, MW 4400Da) following exposure to the indicated doses of 
TcdA for the indicated times.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Cloning stem cells from fetal intestine
a. Sox9 expression in fetal intestine, scale bar, 25um; colonies from intestine (n=10 
biological replicates; colonies of ISC pedigree (n=30 independent experiments). Scale bar, 
75um. Right, ISC colonies stained with indicated antibodies. n=4 technical replicates. 
Bottom, Marker expression following Notch inhibition. n=4 technical replicates. b. ISC 
colony growth. Scale bar, 75um. Right, Clonogenicity of colony cells. n=3 biological 
replicates. c. ISC and TBSC pedigrees and ALI differentiation (tubulin, green; Muc5AC, 
red). Scale bar, 50um left, 25um right top, 25um bottom right; n=7 biological replicates; n=3 
technical replicates; 3 independent experiments d. ALI-differentiated ISC. Scale bar, 50um. 
n=7 biological replicates; n=3 technical replicates; 3 independent experiments. e. PCA using 
2158 genes (>2-fold, p<0.05 by Student t-Test) of ISC and TBSC and corresponding ALI-
differentiated epithelia. f. Markers in ISC and TBSC. n=3 technical replicates.
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Figure 2. Stem cells from fetal small intestine
a. Depiction of small intestine and clones derived from each. Scale bar, 400um; n=3 
biological replicates. b. Heatmap of pedigrees from duodenum (Du), jejunum (JE), and 
ileum (Il). c. Surface views of ALI cultures. Scale bar, 200um; n=30 technical replicates. 
d.,e. Histological sections through ALI cultures at low (Scale bar, 150um) and high Scale 
bar, 50um) magnification. f. Immunofluorescence on sections of ALI cultures with indicated 
antibodies. Scale bar, 75um; n=3 technical replicates. g. PCA map of stem cell gene 
expression from the three major regions of the small intestine together with their 
corresponding ALI-differentiated epithelia.
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Figure 3. Stem cells of fetal colon
a. Depiction of colon and clones derived from each. Scale bar, 75um; n=3 biological 
replicates. b. Expression heatmap of pedigrees from the three major divisions of the colon. c. 
Surface images of ALI cultures. Scale bar, 100um; n=20 technical replicates. d. Histological 
sections through ALI cultures of colon stem cells. Scale bar, 75um. e. Immunofluorescence 
on sections through ALI cultures with indicated antibodies. Scale bar, 50um. f. PCA map of 
gene expression of colon and intestine stem cells. g. Expression heatmap of stem cells of 
small intestine and colon. h. PCA map of gene expression profiles of intestinal stem cells 
and their corresponding ALI-differentiated epithelia.
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Figure 4. Differential gene expression in stem cells of stratified and columnar epithelia
a. PCA map of stem cells of stratified epithelia (corneal epithelium, Cor; mammary gland, 
MG; prostate gland, PG; epidermis, Epi; tracheobronchial epithelium; TB) and columnar 
epithelia (fallopian tube epithelium, FTSC). b. Gene expression in stem cells (stratified 
epithelia n=3 technical replicates; columnar epithelia n=2 technical replicates). c. 
Transcription factors differentially expressed in TBSC and ISC. d. ALI differentiated adult 
terminal ileum stem cells derived from endoscopic biopsy. Scale bar, 50um; n=10 technical 
replicates. e. PCA map of stem cells of adult terminal ileum, colon, fetal ISCs, and stratified 
epithelia. f. Stem cell markers in adult terminal ileum stem cells and TBSCs.
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Figure 5. Genomic stability of ISC in culture
a. Clone selection for pedigree generation. Scale bar, 200um. b. Serial passaging of 
pedigrees. c. CNV BAF and LRR profiles of pedigrees at P5 to P20 and trisomy 12 indicated 
(circle). d. ALI-differentiated pedigree 2 at P7, 17, and P27 stained with H&E (top), Alcian 
blue (middle), and periodic acid-Schiff (bottom). Scale bar, 100um; n=4 technical replicates. 
e. Clonogenicity assay revealing Rhodamine red-stained colonies grown 20 days following 
seeding 1,000 passaged cells. Scale bar, 10mm; n=3 technical replicates. f. Quantification of 
clonogenicity at indicated passage number of ground state stem cells from jejunum (IJejSC) 
and ileum (IIleSC). n=3 biological replicates; Error, SD.
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Figure 6. C. difficile Toxin B effects on in vitro generated colonic epithelia
a. TcdB effects on colonic stem cell-derived epithelia. Scale bar, 100um. n=4 technical 
replicates. b. Tight junction protein claudin 3 (CLDN3; red) and adherens junction marker 
cadherin-17 (CDH17; green) in ALI colonic epithelium TcdB. Scale bar, 50um; n=4 
biological replicates. c. Dextran permeability assay on TcdB-treated ALI colonic epithelia. 
d. 3-D plot of histological scoring by gastrointestinal pathologist according to a standard 0–3 
rating for colonic epithelial integrity. e. Heatmap of thirty-nine genes differentially 
expressed between TcdB (500 pM 24 hrs) and controls (>3-fold and p < 0.05 by Student t-
Test). f. 3-D plot of seven selected genes at time points and doses indicated. n=2 technical 
replicates.
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